Total Funding
95
68
Total FundingGrant raised
Growth Score 95 in past quarter
18 pts
Heat Score 68 in past quarter
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9920
Alveo is a pre-clinical stage medical diagnostics company .
- Erik Tyrrell-Knott: Chief Business & Strategy Officer
- Slava Elagin: Chief Technology Officer
About the Company
Alveo Technologies is changing the world by applying cutting edge advances in sensing, microfluidics, and bioassays to create the next-generation of disease and personal care diagnostic devices.Their innovative products connect and empower consumers, healthcare professionals and treatment providers with the ability to know sooner, act faster, and
make better-informed decisions. Advanced diagnostics clear the path to more personalized medicine and better outcomes.